Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel...
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024
Project: SYSCID
Updated at: 29-04-2024